ANI Pharmaceuticals Correlations

ANIP Stock

USD 55.86 0.76 1.38%

The current 90-days correlation between ANI Pharmaceuticals and Eagle Pharmaceuticals is 0.09 (i.e., Significant diversification). The correlation of ANI Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

ANI Pharmaceuticals Correlation With Market

Very weak diversification

The correlation between ANI Pharmaceuticals and DJI is 0.4 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding ANI Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ANI Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

To learn how to invest in ANI Stock, please use our How to Invest in ANI Pharmaceuticals guide.

Moving together with ANI Stock

0.61	VRAX	Virax Biolabs Group	Pair Corr
0.62	VTGN	VistaGen Therapeutics	Pair Corr

Moving against ANI Stock

0.54	DMAC	DiaMedica Therapeutics	Pair Corr
0.45	VRDN	Viridian Therapeutics	Pair Corr
0.36	SABSW	SAB Biotherapeutics	Pair Corr
0.35	VRNA	Verona Pharma PLC	Pair Corr
0.32	ELVN	Enliven Therapeutics	Pair Corr

Related Correlations Analysis

	EGRX	PAHC	DCPH	PBH	ALKS	RDY	COLL	PCRX	PROC	SSIC
EGRX		-0.63	0.31	-0.4	-0.01	0.77	0.52	-0.58	0.51	-0.29	EGRX
PAHC	-0.63		-0.14	0.46	0.18	-0.69	-0.45	0.73	-0.47	0.29	PAHC
DCPH	0.31	-0.14		-0.43	0.13	0.49	0.31	-0.02	0.33	-0.27	DCPH
PBH	-0.4	0.46	-0.43		0.26	-0.67	-0.81	0.36	-0.88	0.84	PBH
ALKS	-0.01	0.18	0.13	0.26		0.06	0.04	0.23	-0.16	0.47	ALKS
RDY	0.77	-0.69	0.49	-0.67	0.06		0.77	-0.59	0.75	-0.51	RDY
COLL	0.52	-0.45	0.31	-0.81	0.04	0.77		-0.4	0.86	-0.72	COLL
PCRX	-0.58	0.73	-0.02	0.36	0.23	-0.59	-0.4		-0.34	0.23	PCRX
PROC	0.51	-0.47	0.33	-0.88	-0.16	0.75	0.86	-0.34		-0.82	PROC
SSIC	-0.29	0.29	-0.27	0.84	0.47	-0.51	-0.72	0.23	-0.82		SSIC
	EGRX	PAHC	DCPH	PBH	ALKS	RDY	COLL	PCRX	PROC	SSIC

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

PROC	+ 0.86	COLL
SSIC	+ 0.84	PBH
RDY	+ 0.77	EGRX
COLL	+ 0.77	RDY
PROC	+ 0.75	RDY
PCRX	+ 0.73	PAHC

High negative correlations

PROC	- 0.88	PBH
SSIC	- 0.82	PROC
COLL	- 0.81	PBH
SSIC	- 0.72	COLL
RDY	- 0.69	PAHC
RDY	- 0.67	PBH

Risk-Adjusted Indicators

There is a big difference between ANI Stock performing well and ANI Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze ANI Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
EGRX	3.94	(1.28)	0.00	(1.22)	0.00	0.00	9.24	(8.24)	53.71
PAHC	2.01	0.28	0.17	0.24	1.63	(2.34)	5.36	(2.45)	15.47
DCPH	1.66	(0.22)	0.00	(0.90)	0.00	0.00	3.27	(3.25)	9.66
PBH	0.92	0.20	0.15	0.37	0.92	(1.00)	1.90	(1.76)	4.90
ALKS	1.70	(0.14)	(0.04)	0.00	2.11	(1.82)	4.14	(3.59)	9.74
RDY	0.95	(0.31)	0.00	(0.25)	0.00	0.00	1.46	(2.20)	6.89
COLL	1.88	(0.36)	0.00	(0.24)	0.00	0.00	3.59	(4.47)	12.29
PCRX	1.88	0.23	0.11	0.29	1.93	(2.10)	3.96	(3.21)	10.38
PROC	4.37	(1.64)	0.00	(2.34)	0.00	0.00	7.55	(12.37)	63.61
SSIC	1.09	0.11	0.05	0.29	1.04	(1.35)	2.89	(1.82)	7.09

ANI Pharmaceuticals Corporate Management

Meredith Cook	General VP	Profile
Elizabeth JD	Chief Disease	Profile
Krista Davis	Senior Officer	Profile
Muthusamy RPh	COO RD	Profile
Thomas Rowland	Senior Brands	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC